We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Gynaecological
6014
Poster (Digital)
Clinical
Comparison of DVH of pelvic bone marrow in 2D vs VMAT and its clinical outcomes in carcinoma cervix
Sankalp Naidu, India
PO-1409
Dosimetry predictors for haematological toxicity in chemoradiotherapy for cervical cancer
Mohammed Abdul-Latif, United Kingdom
PO-1410
[18F]FDG-PET predicts overall survival in patients with locally advanced cervical cancer.
Camilla Satragno, Italy
PO-1412
IORT AT THE TIME OF PELVIC EXENTERATION IN PERSISTENT OR RECURRENT GYNECOLOGIC MALIGNANCIES
Barbara Alicja Jereczek-Fossa, Italy
PO-1413
Radiotherapy as Definitive Treatment for Vulvar Carcinoma
Claudia Franco de Sa, Portugal
PO-1415
Usefulness of magnetic resonance imaging in the pre-surgical evaluation of endometrial cancer
Maria Cerrolaza, Spain
PO-1416
The association between PET-CT metabolic parameters, SCCA and survival in cervical cancer patients.
Marcin Miszczyk, Poland
PO-1417
Programmed death ligand (PD-L1) expression and survival outcome in radically treated cervical cancer
Aparna Mullangath Prakasan, India
PO-1418
Outcomes of SBRT for oligometastatic patients with lymph node metastases from gynaecological cancer.
Giuseppe Facondo, Italy
PO-1419
Cardiac metastasis in uterine cervical cancer: Systematic review and case report
Inga-Malin Simek, Austria
PO-1420
Image-guided brachytherapy for cervical cancer – Experience at Carlos Van Buren Hospital
Jose Antonio Solis Campos, Chile
PO-1421
Feasibility of bone marrow sparing VMAT and Dixon MRI for the PROTECT study
Anouk Corbeau, The Netherlands
PO-1422
intensity modulated radiotherapy in vulvar cancer: results from an observational single-center study
Erika Galietta, Italy
PO-1423
CBCT-guided online adaptive radiotherapy in patients with cervical cancer
Lisanne Zwart, The Netherlands
PO-1424
Risk factors for unplanned acute care visits in gynecologic oncology patients receiving radiotherapy
Jennifer Croke, Canada
PO-1427
Treatment outcomes in Uterine Sarcomas: A Real-world experience
Srinivasa GY, India
PO-1428
Updated results of toxicity and clinical outcome in carcinoma cervix treated with IG-IMRT and IGBT
Vachaspati Kumar Mishra, India
PO-1429
Re-irradiation with intensity-modulated radiation therapy for pelvic recurrent cervical cancer
Hye Jin Kang, Korea Republic of
PO-1430
A phase I/II study of SBRT boost in patients with cervical cancer who are ineligible for ICBT
Kei Ito, Japan
PO-1431
The role of inflammation markers in cervical cancers undergoing definitive chemoradiation
Ludovica Forlani, Italy
PO-1432
HAPPY protocol impact on psychological well-being in patients with gynecological cancer
Valentina Lancellotta, Italy
PO-1434
Pretreatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Cervical Cancer
Fátima Aurora Lima Aires, Portugal
PO-1435
The Dosimetric Implications of Sentinel Node Mapping on Adjuvant Radiotherapy for Endometrial Cancer
Thomas Charlton, United Kingdom
PO-1436